Neuroelectrics, a Spanish deeptech company specializing in neurotechnology, has received recognition for its pioneering work in brain science and neurological innovation. Ana Maiques, co-founder and Chief Executive Officer of the company, was awarded the FEDEPE 2026 Women’s Innovation and Entrepreneurship Award, cementing her position as a leading figure in Spain’s technology sector.
The accolade recognizes Maiques’ efforts in establishing Neuroelectrics as a significant player in the global neurotechnology landscape. The company’s work spans multiple areas within neuroscience, including advanced brain research methodologies, diagnostic approaches for neurological conditions, and the development of non-pharmacological treatment solutions centered on brain stimulation technologies.
Leadership and Vision
Maiques’ recognition underscores the growing prominence of women entrepreneurs in Spain’s deeptech sector, particularly in fields requiring substantial scientific expertise and technological sophistication. The award acknowledges not only her entrepreneurial achievements but also her contribution to positioning Spanish neurotechnology among the world’s most competitive and innovative sectors.
Neuroelectrics operates at the intersection of neuroscience and engineering, developing solutions that address critical gaps in how neurological diseases are diagnosed and treated. The company’s focus on brain stimulation-based therapies represents an alternative approach to traditional pharmacological interventions, opening new possibilities for patients with conditions currently lacking effective treatment options.
Spanish Neurotechnology on the Rise
The FEDEPE award reflects broader momentum in Spain’s innovation ecosystem, where deeptech companies are increasingly gaining international recognition and investment. Neurotechnology specifically has emerged as a strategic priority for European research and development, driven by growing healthcare demands and advances in brain imaging and stimulation technologies.
The recognition of Maiques and her work with Neuroelectrics sends a signal about Spain’s capacity to nurture ambitious scientific entrepreneurs who can compete on a global scale. The award also highlights the importance of supporting women-led ventures in sectors traditionally dominated by men, where diverse leadership can contribute fresh perspectives to complex scientific and medical challenges.
Broader European Context
Within the European startup ecosystem, companies like Neuroelectrics exemplify the continent’s strength in deeptech innovation. The recognition of Spanish neurotechnology leadership comes as the EU continues to prioritize brain research and neuroscience through initiatives aimed at understanding neurological diseases and developing next-generation therapies. This convergence of entrepreneurial drive, scientific talent, and policy support positions Spain alongside other European hubs in the race to develop transformative neurotechnology solutions.
As regulatory frameworks around brain stimulation and digital health continue to evolve across Europe, companies with expertise in this domain are well-positioned to address unmet medical needs while establishing commercial viability in expanding markets. Maiques’ award recognition validates both the individual entrepreneur and the larger ecosystem supporting neurotechnology innovation in Spain and across the continent.